DSM shareholders approve DSM-Firmenich merger at Extraordinary General Meeting
Mon, January 23, 2023 at 6:30 PM GMT+1
This is a press release by Koninklijke DSM N.V. (Royal DSM) in connection with the public exchange offer by Danube AG (to be renamed DSM-Firmenich AG) for all the issued and outstanding ordinary shares in the share capital of DSM (the Exchange Offer). This press release contains information within the meaning of Article 7(1) of the European Market Abuse Regulation (596/2014). This press release does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities. Any offer will be made only by means of the offering circular dated 22 November 2022 (the Offering Circular) approved by the Dutch Authority for Financial Markets (Stichting Autoriteit Financiële Markten). This press release is not for general release, publication or distribution, in whole or in part, in or into, directly or indirectly, the United States or any other jurisdiction where such release, publication or distribution would violate applicable laws or regulations. Capitalized terms used but not defined in this press release will have the meaning as set forth in the Offering Circular.
HEERLEN, Netherlands, Jan. 23, 2023 /PRNewswire/ -- Royal DSM, a global purpose-led science-based company, today held an Extraordinary General Meeting of Shareholders (EGM). The DSM Shareholders approved the proposed merger between DSM and Firmenich International SA (Firmenich) and voted in favour of all related resolutions as set out in the notice of the EGM.